0
0
1/9/23 at 11:46pm
Organization
CNBC
Author
Spencer Kimball
44 words
0
Comments
Most seniors who are eligible for the treatment will have to pay for it out of pocket because Medicare has limited coverage to people participating in studies.
You are the first to view
https://www.cnbc.com/2023/01/09/most-alzheimers-patients-would-pay-up-to-26500-per-year-for-leqembi.html
Create an account
or login to join the discussion